Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion type Assertion NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_head.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion wasGeneratedBy ECO_0000203 NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_provenance.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion wasDerivedFrom befree-2016 NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_provenance.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion SIO_000772 12619114 NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_provenance.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion evidence source_evidence_literature NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_provenance.
- NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_assertion description "[Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ovarian tumors (benign, borderline, and malignant) and histological subtypes (serous, mucinous, endometrioid, clear cell), as well as in BRCA1-associated hereditary ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385857.RAw6Vol1s_o-hTL_1uRjLR74dRUzrOTKUrTm7LchsSz50130_provenance.